Japan-based Eisai Pharmaceuticals is planning to expand its manufacturing plant in Visakhapatnam in Andhra Pradesh and set up an innovation centre to support its new drug development programmes.
Sanjit Singh Lamba, managing director of Eisai Pharmaceuticals India, was quoted as saying by Business Standard: “We have a facility to manufacture two billion capsules annually.”
He added: “We are ramping up our active pharmaceutical ingredients (APIs) manufacturing unit and developing an innovation centre for new formulations at Visakhapatnam.”
Eisai sells cancer and central nervous disorder drugs in India. It has a manufacturing unit in Visakhapatnam (Vizag) which largely caters for export.
Image Credit : thehindu.com